These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18410226)

  • 1. Significance of serum TRACP in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Yam LT
    J Bone Miner Res; 2008 Aug; 23(8):1287-95. PubMed ID: 18410226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
    Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ; Simons RM; Yam LT
    Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ; Takahashi K; Sun SZ; Yam LT
    Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
    Luukkonen J; Pascual LM; Patlaka C; Lång P; Turunen S; Halleen J; Nousiainen T; Valkealahti M; Tuukkanen J; Andersson G; Lehenkari P
    PLoS One; 2017; 12(8):e0182904. PubMed ID: 28792533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
    Janckila AJ; Nakasato YR; Neustadt DH; Yam LT
    J Bone Miner Res; 2003 Oct; 18(10):1916-9. PubMed ID: 14584907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
    Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
    Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
    Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients.
    Iwadate H; Kobayashi H; Kanno T; Asano T; Saito R; Sato S; Suzuki E; Watanabe H; Ohira H
    Int J Rheum Dis; 2014 Jan; 17(1):50-6. PubMed ID: 24472267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ; Lederer ED; Price BA; Yam LT
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
    Takahashi K; Janckila AJ; Sun SZ; Lederer ED; Ray PC; Yam LT
    Clin Chim Acta; 2000 Nov; 301(1-2):147-58. PubMed ID: 11020469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
    Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
    J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
    Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
    Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
    Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E
    Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.